The scientific, economic and social benefits of biotechnology are clear, yet government regulations continue to stifle new biotech innovations that will help our economy grow. Dr. Nina Fedoroff, former science and technology advisor for the U.S. State Department and professor of biology at Pennsylvania State University, emphasized this in a New York Times op-ed article about the safety and efficacy of biotech crops.
She points out GM crops lower costs for farmers by producing higher yields on less land, while also benefiting the environment with reduced pesticide use and tilling. These advances are particularly important to help feed a quickly growing world population, but because of complicated regulatory hurdles there are only a handful of varieties of approved biotech crops. Dr. Fedoroff sums it up and writes, “It is time to relieve the regulatory burden slowing down the development of genetically modified crops. ” Read more.